Udo Holtick
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 29
- Acute Myeloid Leukemia Research 9
- Genetics top 5%
- Immunology top 5%
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 7
- Oncology top 5%
- CAR-T cell therapy research 18
- Transplantation top 5%
-
- Lymphoma Diagnosis and Treatment 8
-
- Acute Lymphoblastic Leukemia research 7
-
- Cytomegalovirus and herpesvirus research 7
Udo Holtick
83 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 99
- Hematology 546
- Genetics 322
- Immunology 631
- Oncology 728
- Transplantation 56
Countries citing papers authored by Udo Holtick
This map shows the geographic impact of Udo Holtick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Udo Holtick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Udo Holtick more than expected).
Fields of papers citing papers by Udo Holtick
This network shows the impact of papers produced by Udo Holtick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Udo Holtick. The network helps show where Udo Holtick may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Udo Holtick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 13 | |
| 10 | 2023 | 10 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 10 | |
| 14 | 2019 | 6 | |
| 15 | 2017 | 85 | |
| 16 | 2016 | 18 | |
| 17 | 2015 | 2 | |
| 18 | 2013 | 28 | |
| 19 | 2011 | 5 | |
| 20 | 2005 | 76 |
About Udo Holtick
Udo Holtick is a scholar working on Hematology, Oncology, Transplantation, Immunology and Genetics, having authored 87 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (29 papers), CAR-T cell therapy research (18 papers), Acute Myeloid Leukemia Research (9 papers), Immune Cell Function and Interaction (8 papers), Lymphoma Diagnosis and Treatment (8 papers), Immunotherapy and Immune Responses (7 papers), Acute Lymphoblastic Leukemia research (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Hematology (546 citations), Genetics (322 citations), Immunology (631 citations), Oncology (728 citations) and Transplantation (56 citations). Udo Holtick has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Christof Scheid, Sebastian Theurich, Michael von Bergwelt‐Baildon, Alexander Shimabukuro‐Vornhagen, Anne M. Dickinson, Catharien M. U. Hilkens, Xiaonong Wang, Matthew Collin, Michael Hallek and Muzlifah Haniffa. Their work appears in journals such as European Journal Of Haematology, Blood, Annals of Hematology, Bone Marrow Transplantation and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.